Study Results Show That Oral Contraceptives/Hormone Replacement Therapy May Protect Against Brain Aneurysms
Findings Announced at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting
CARLSBAD, Calif., July 30 /PRNewswire-USNewswire/ -- Results from a retrospective, case-control study presented today at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting could have significant implications for women at risk of brain aneurysms as data shows that oral contraceptives (OC) and hormone replacement therapy (HRT) may yield the additional benefit of protecting against the formation and/or rupture of brain aneurysms – balloon-like sacks that form in a weakened artery wall and, upon bursting, can cause severe disability or death.
Teva Admits to Making False Statements in US Gianviâ„¢ Label and Agrees to Corrective Measures
WAYNE, N.J., June 17 /PRNewswire/ -- In a June 16, 2010 proceeding before Judge Virginia Kendall in US Federal Court in the Northern District of Illinois, Teva Pharmaceuticals USA Inc. admitted that the Physician Prescribing Information included with packages of its oral contraceptive Gianviâ„¢, falsely claimed that the ethinyl estradiol in the product was stabilized by Bayer's patented "betadex as a clathrate" formulation, and in fact, that Gianvi does not have Bayer's patented stabilization formulation.
Gallbladder Disease - A Dangerous Side Effect of a 4th Generation Birth Control Pill
Many women are suffering from gallbladder problems that were caused by one of the first fourth generation birth control pills to come on the market. This particular oral contraceptive is a combination hormone contraceptive. It contains a synthetic form of progestin called drospirenone and another hormone, estrogen, called ethinyl estradiol.
|
|
 |
 |
Study Results Show That Oral Contraceptives/Hormone Replacement Therapy May Protect Against Brain Aneurysms
Findings Announced at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting
CARLSBAD, Calif., July 30 /PRNewswire-USNewswire/ -- Results from a retrospective, case-control study presented today at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting could have significant implications for women at risk of brain aneurysms as data shows that oral contraceptives (OC) and hormone replacement therapy (HRT) may yield the additional benefit of protecting against the formation and/or rupture of brain aneurysms – balloon-like sacks that form in a weakened artery wall and, upon bursting, can cause severe disability or death.
Teva Admits to Making False Statements in US Gianviâ„¢ Label and Agrees to Corrective Measures
WAYNE, N.J., June 17 /PRNewswire/ -- In a June 16, 2010 proceeding before Judge Virginia Kendall in US Federal Court in the Northern District of Illinois, Teva Pharmaceuticals USA Inc. admitted that the Physician Prescribing Information included with packages of its oral contraceptive Gianviâ„¢, falsely claimed that the ethinyl estradiol in the product was stabilized by Bayer's patented "betadex as a clathrate" formulation, and in fact, that Gianvi does not have Bayer's patented stabilization formulation.
Seasonale Birth control Pill that is same but Different
Seasonale birth control pill has been approved by FDA. A new choice in oral contraceptive for woman for preventing of pregnancy. Seasonale s an extended- regimen birth control pill which means it is designed to extend the time between your expected menstrual periods so you get them once every 3 months instead of every month. Seasonale is 99 percent effective in preventing pregnancy when taken as directed by your doctor.
Seasonale - Extended Cycle Oral Contraceptive
Seasonal oral contraceptive is an extended- regimen birth control pill, which means it is helps to extend the time between your periods so you get them once every 3 months instead of every month. In simple words, it extends time between your periods. Seasonale is 99 percent effective in preventing pregnancy when taken as directed.
|
 |
|
